BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noto A, Cassin R, Mattiello V, Reda G. The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. J Clin Med 2021;10:2064. [PMID: 34065833 DOI: 10.3390/jcm10102064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Barcellini W, Fattizzo B. Diagnosis and Management of Autoimmune Hemolytic Anemias. JCM 2022;11:6029. [DOI: 10.3390/jcm11206029] [Reference Citation Analysis]
2 Robak E, Robak T. Bruton's Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives. J Clin Med 2022;11:2807. [PMID: 35628931 DOI: 10.3390/jcm11102807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 Cavarretta CA, Visentin A, Pravato S, Piva E, Piazza F, Basso D, Trentin L. Anaemia during venetoclax ramp-up phase: Do not forget unusual causes. Int J Lab Hematol 2022. [PMID: 35538897 DOI: 10.1111/ijlh.13875] [Reference Citation Analysis]
4 Robak T, Witkowska M, Smolewski P. The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions. Cancers 2022;14:771. [DOI: 10.3390/cancers14030771] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
5 Autore F, Pasquale R, Innocenti I, Fresa A, Sora' F, Laurenti L. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers (Basel) 2021;13:5804. [PMID: 34830959 DOI: 10.3390/cancers13225804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]